Spyre Therapeutics board member Peter Harwin resigns; annual meeting approves ESPP amendment

Filed May 29, 2026 · Period ending May 27, 2026 · ~1 min read

Key Changes

• medium

  Board member Peter Harwin resigned effective May 27, 2026, reducing board size from eight to seven directors. Company states resignation was not due to any disagreement on operations, policies, or practices.

  Item 5.02 verify on EDGAR →
• low

  Stockholders approved amended 2016 Employee Stock Purchase Plan with 66.9M votes for versus 45.5K against, representing strong support for employee benefit program.

  Item 5.07 verify on EDGAR →
• low

  Three Class I directors elected to three-year terms through 2029: Mark McKenna, Cameron Turtle, and Laurie Stelzer, all receiving majority shareholder support.

  Item 5.07 verify on EDGAR →